TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
about
Transglutaminase is a tumor cell and cancer stem cell survival factorTransamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsPTK7 regulates Id1 expression in CD44-high glioma cells.Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells.Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis.The complex role of transglutaminase 2 in glioblastoma proliferation.On-Chip Clonal Analysis of Glioma-Stem-Cell Motility and Therapy Resistance.The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.Whether CD44 is an applicable marker for glioma stem cells.Research on human glioma stem cells in China.Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival.In Search for Reliable Markers of Glioma-Induced Polarization of Microglia.A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells
P2860
Q26799862-ED6B21EB-B992-4DEB-84D4-17E00C114A55Q33728989-DD2A13B7-7870-4D77-B42D-F3C5B80A3541Q34233236-57CDCB9B-62D7-407C-A394-71A3580A61FBQ35609259-21892089-3786-438D-9E60-B74193399B31Q35624661-74BAFE38-09D6-43FE-81C4-2E6FDCB4CE42Q35788789-4A754818-9427-4B1F-971A-78900A96F94AQ35803718-0D98F713-8502-4D23-A94F-0125A27A4A28Q35997569-F20A7660-DB2C-4211-A7DE-268E9948020BQ36251782-90574A7B-7645-40CD-9924-F3316B04982DQ38824727-7D091A00-AEEA-4F2B-95A5-A3E7BA90EC51Q41207207-52427DD4-A649-4641-9B6A-7333CDD1EC58Q42062405-0B75E321-8597-4879-818F-FBFDC22EF3A5Q47095291-9F983B63-FCF5-4F1A-8EA0-807BF39C9CFAQ47151420-A327AA74-BD6F-44C4-9566-C0D314272ECAQ48151426-F9975DB5-21D3-4B75-8A62-8A63C29B420BQ50055579-F5FA9E31-462E-4D3F-9198-C1754EA7A676Q55452003-AEDAF015-6AF7-4002-8E7A-A74FDEC1CA37Q57821053-14B9E81C-4169-44E2-AC2A-991AC1C958CD
P2860
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
@en
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
@nl
type
label
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
@en
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
@nl
prefLabel
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
@en
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
@nl
P2093
P2860
P356
P1433
P1476
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
@en
P2093
Aij-lie Kwan
Fu-rong Chen
Ho-keung Ng
Jesse C S Pang
Qun-ying Yang
Zhong-ping Chen
P2860
P304
P356
10.1093/NEUONC/NOT079
P577
2013-07-21T00:00:00Z